Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?

Jakob Wested, Timo Minssen, Esther Van Zimmeren

    Abstract

    As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
    Original languageEnglish
    JournalLife Sciences Intellectual Property Review (LSIPR)
    Issue number13/7 2018
    Number of pages6
    Publication statusPublished - 13 Jul 2018

    Keywords

    • Faculty of Law
    • patents gene editing
    • CRISPR-Cas 9
    • European Patent Office
    • Appeal
    • Broad Institute

    Fingerprint

    Dive into the research topics of 'Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?'. Together they form a unique fingerprint.

    Cite this